Koji Masuda
Overview
Explore the profile of Koji Masuda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
1183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saeki H, Ohya Y, Arakawa H, Ichiyama S, Katsunuma T, Katoh N, et al.
Allergol Int
. 2025 Feb;
PMID: 39986987
This is an abridged edition of English version of the Clinical Practice Guidelines for the Management of Atopic Dermatitis 2024. Atopic dermatitis (AD) is a disease characterized by relapsing eczema...
2.
Saeki H, Ohya Y, Arakawa H, Ichiyama S, Katsunuma T, Katoh N, et al.
J Dermatol
. 2024 Dec;
52(2):e70-e142.
PMID: 39707640
This is the English version of the 2024 clinical practice guidelines for the management of atopic dermatitis (AD). AD is a disease characterized by relapsing eczema with pruritus as a...
3.
Masuda K, Masuda K, Ikeda K, Ikeda K, Endo A, Endo A, et al.
J Infect Chemother
. 2024 Dec;
31(3):102580.
PMID: 39672323
Background And Objectives: Vancomycin (VAN) is one of therapeutic agents for severe infections, and its efficacy and safety are subject to therapeutic drug monitoring. However, there is a lack of...
4.
Fukunaga A, Kakei Y, Murakami S, Kan Y, Masuda K, Jinnin M, et al.
Front Immunol
. 2024 Oct;
15():1441478.
PMID: 39351222
Background: For treating patients with refractory chronic spontaneous urticaria (CSU) resistant to standard doses of 2 generation H1-antihistamines (H1AH) the International and Japanese guidelines recommend increasing H1AH dose. The latter...
5.
Sato T, Masuda K, Sano C, Matsumoto K, Numata H, Munetoh S, et al.
Micromachines (Basel)
. 2024 Sep;
15(9).
PMID: 39337724
Microreactor technologies have emerged as versatile platforms with the potential to revolutionize chemistry and materials research, offering sustainable solutions to global challenges in environmental and health domains. This survey paper...
6.
Kido-Nakahara M, Onozuka D, Izuhara K, Saeki H, Nunomura S, Takenaka M, et al.
J Allergy Clin Immunol Glob
. 2024 Sep;
3(4):100317.
PMID: 39253106
Background: Atopic dermatitis (AD) is a common chronic eczematous skin disease with severe pruritus. Several new therapeutic agents for AD such as dupilumab, an anti-IL-4Rα antibody, have been developed in...
7.
Tamagawa-Mineoka R, Taniguchi M, Ioka N, Hattori J, Mizutani H, Masuda K, et al.
Contact Dermatitis
. 2024 May;
91(3):259-260.
PMID: 38757244
No abstract available.
8.
Houghton M, Kashanian S, Derrien T, Masuda K, Vollmer F
ACS Photonics
. 2024 Mar;
11(3):892-903.
PMID: 38523742
Optical microcavities, specifically, whispering-gallery mode (WGM) microcavities, with their remarkable sensitivity to environmental changes, have been extensively employed as biosensors, enabling the detection of a wide range of biomolecules and...
9.
Simpson E, Silverberg J, Worm M, Honari G, Masuda K, Sygula E, et al.
J Am Acad Dermatol
. 2024 Jan;
90(6):1190-1199.
PMID: 38296199
Background: Despite high disease burden, systemic treatment options for patients with atopic hand and/or foot dermatitis (H/F AD) are limited. Objectives: To evaluate efficacy and safety of dupilumab in H/F...
10.
Kido-Nakahara M, Onozuka D, Izuhara K, Saeki H, Nunomura S, Takenaka M, et al.
Allergol Int
. 2023 Dec;
73(2):332-334.
PMID: 38151410
No abstract available.